Cost-Effectiveness Analysis of Direct Oral Anticoagulants Versus Vitamin K Antagonists for Venous Thromboembolism in China

Cost-Effectiveness Analysis of Direct Oral Anticoagulants Versus Vitamin K Antagonists for Venous Thromboembolism in China

Background: The drug therapy of venous thromboembolism (VTE) presents a significant economic burden to the health-care system in low- and middle-income countries. To understand which anticoagulation therapy is most cost-effective for clinical decision-making , the cost-effectiveness of apixaban (API...

Full description

Bibliographic Details
Main Authors: Ke-Xin Sun, Bin Cui, Shan-Shan Cao, Qi-Xiang Huang, Ru-Yi Xia, Wen-Jun Wang, Jing-Wen Wang, Feng Yu, Yi Ding
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-10-01
Series:Frontiers in Pharmacology
Subjects:
VTE
DOAC
CEA = cost-effectiveness analysis
China
LMWH (low molecular weight heparin)
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.716224/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2021.716224/full

Similar Items